GrantExec, a Euna Solutions® company

Federal Health Grants

Explore 3,568 grant opportunities

Limited Competition for the HEAL Initiative: HEALthy Brain and Child Development (HBCD) Study (Collaborative U01- Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 17, 2026

Date Added

May 6, 2025

This funding opportunity is designed for eligible organizations to conduct research on how prenatal and perinatal exposures affect child brain and behavioral development, supporting a large-scale study involving pregnant women and their children.

Health
State governments
Leadership Education in Neurodevelopmental and Other Related Disabilities (LEND)
$3,670,000
U.S. Department of Health and Human Services (Health Resources and Services Administration)
Federal

Application Deadline

Jul 10, 2026

Date Added

Dec 12, 2025

This program provides funding to public and nonprofit organizations to develop interdisciplinary training for professionals and families supporting children and youth with autism and other developmental disabilities.

Health
Nonprofits
BJA FY25 Second Chance Act Training and Technical Assistance Program
$605,000
U.S. Department of Justice (Bureau of Justice Assistance)
Federal

Application Deadline

Apr 10, 2026

Date Added

Mar 19, 2026

This funding opportunity provides financial support to organizations that develop and enhance reentry programs aimed at helping individuals successfully reintegrate into their communities and reduce recidivism rates.

Law Justice and Legal Services
Public and State controlled institutions of higher education
Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource (Collaborative U24 - Clinical Trials not allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Sep 30, 2025

Date Added

May 23, 2025

This funding opportunity is designed to support collaborative research projects that investigate the long-term neurological effects of adolescent alcohol consumption on brain development and behavior in adulthood, inviting a wide range of eligible applicants from various sectors.

Health
State governments
Strengthening public health efforts to protect and improve health in the Democratic Republic of the Congo (DRC)
$10,000,000
U.S. Department of Health and Human Services (Centers for Disease Control-GHC)
Federal

Application Deadline

Aug 14, 2026

Date Added

Aug 23, 2025

This funding opportunity provides financial support to various organizations working to strengthen public health systems in the Democratic Republic of the Congo, focusing on improving disease detection, response, and overall health security.

Health
State governments
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
$50,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 10, 2024

Date Added

Nov 22, 2023

This funding opportunity provides financial support for early-stage researchers transitioning to independent careers in clinical and translational science, enabling them to conduct small-scale research projects that can lead to larger studies.

Health
State governments
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
$275,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 7, 2025

Date Added

Apr 11, 2023

This funding opportunity supports the development of innovative tools and technologies aimed at advancing research and treatment in kidney, urologic, and hematologic diseases, encouraging projects that push scientific boundaries and have broad applications beyond individual research interests.

Food and Nutrition
State governments
Performance and Reliability Evaluation for Continuous Modifications and Useability of Artificial Intelligence (PRECISE-AI)
Contact for amount
Advanced Research Projects Agency for Health (ARPA-H)
Federal

Application Deadline

Jan 15, 2025

Date Added

Jan 8, 2025

This program provides funding to interdisciplinary teams developing automated tools to ensure the accuracy and reliability of AI models used in healthcare, addressing performance degradation and enhancing patient safety.

Health
Unrestricted
AHRQ Mentored Career Enhancement Awards for Established Investigators in Patient-Centered Outcome Research (K18)
$550,000
U.S. Department of Health & Human Services (Agency for Health Care Research and Quality)
Federal

Application Deadline

Mar 21, 2026

Date Added

Dec 8, 2021

This grant provides funding for experienced researchers to enhance their skills in patient-centered outcomes research, enabling them to conduct impactful studies that improve healthcare delivery and address health disparities.

Health
State governments
FY26 Guidelines for Brownfield Cleanup Grants
$4,000,000
U.S. Environmental Protection Agency
Federal

Application Deadline

Jan 28, 2026

Date Added

Nov 21, 2025

This funding opportunity provides financial support to eligible local and state governments, tribes, and nonprofit organizations for cleaning up contaminated properties they own, helping to revitalize communities affected by pollution and disinvestment.

Environment
City or township governments
National Center for Child Traumatic Stress - Category 1
$8,000,000
U.S. Department of Health and Human Services (Substance Abuse and Mental Health Services Administration)
Federal

Application Deadline

Jul 13, 2026

Date Added

Dec 11, 2025

This grant provides funding to nonprofit organizations and government entities to establish a national center that improves trauma-informed care for children and youth across the United States.

Health
Nonprofits
DOD Lung Cancer, Patient-Centered Outcomes and Survivorship Award
$2,080,000
U.S. Department of Defense (Dept. of the Army -- U.S.AMRAA)
Federal

Application Deadline

Aug 7, 2024

Date Added

Jul 25, 2024

The Patient-Centered Outcomes and Survivorship Award supports high-risk, high-reward research studies that span the spectrum of behavioral health science, survivorship, health outcomes and comparative effectiveness research, including quality of life, symptom and side effect management, resilience, co-morbid conditions, and examining the physical, psychological, social, and economic effects of lung cancer among patients and their families.The overall intent of the FY24 LCRP Patient-Centered Outcomes and Survivorship Award is to promote evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research studies may include, but are not limited to:Studies to examine and improve quality of life, decision-making, and symptom and side effect management (e.g., toxicity of treatment, palliative/supportive care, psychological distress and anxiety).Studies to investigate the impact of prevention, diagnostics, treatment, or health care delivery approaches on health outcomes.Studies to assess the relationship(s) between behavioral, cognitive, and/or social functioning in relation to lung cancer detection, initiation, progression, treatment, and rehabilitation.Studies into the psychological health and well-being of those affected by lung cancer (e.g., patients, family members).Development and testing for efficacy of lifestyle interventions and symptom management approaches to minimize disease risk and maximize quality of life.Key aspects of this award mechanism are:Impact: The Patient-Centered Outcomes and Survivorship Award is intended to support research that demonstrates the potential to have a major impact on patient outcomes. Research should challenge paradigms with respect to impact on patient care and outcomes. Proposed projects may include translational or clinical research, including pilot clinical trials. Impactful research will accelerate the movement of promising ideas into clinical applications, generate knowledge to improve clinical guidelines, or significantly advance behavioral, cognitive, and/or social functioning related to the target population.Study Design: Applications should clearly articulate the chosen design of the study. Basic studies should demonstrate research strategy, feasibility, and how the study relates to the human experience with lung cancer. Studies entailing retrospective or prospective recruitment should define the type of architecture of the study (e.g., descriptive, correlational, field experimental, meta-analyses). Study populations should be defined. The rationale should support the chosen study design with statistical evaluation to back the design. Questionnaires should be described in sufficient detail to justify interpretation of potential results.Preliminary Data: The Patient-Centered Outcomes and Survivorship Award requires preliminary data for all studies that propose the active (prospective) recruitment of human subjects. Studies not proposing active recruitment of human subjects are not required to present preliminary data but should be supported by sound reasoning and relevant literature.Patient Advocate Participation: Applications to the Patient-Centered Outcomes and Survivorship Award funding opportunity are encouraged to include a patient advocate. As part of the research team, the patient advocate would assist in the development of the research question, project design, oversight, recruitment, and evaluation, as well as other significant aspects of the proposed project. The patient advocate will be a person with a history of lung cancer diagnosis. As a lay representative, the patient advocate should be active in a cancer advocacy organization. Interactions with other team members should be well integrated and ongoing, not limited to attending seminars and semi-annual meetings. The role of the patient advocate should be focused on providing objective input on the research and its potential impact for individuals with or at risk for lung cancer.

Science and Technology
Unrestricted
Medical Devices for Pediatric Population Affected by Substance Use and Addiction (R43 - Clinical Trials Optional)
$400,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 26, 2025

Date Added

Nov 22, 2024

This funding opportunity supports small businesses in developing innovative medical devices specifically designed to help children and adolescents struggling with substance use and addiction.

Education
Small businesses
Native Public Health Resilience Planning
$200,000
HHS-IHS (Indian Health Service)
Federal
Rolling

Application Deadline

Not specified

Date Added

Mar 21, 2023

The purpose of this program is to assist applicants in establishing goals and performance measures, assess their current management capacity, and determine if Public Health Department development is practicable. Specifically, programs should assess the availability and applicability of the 10 Essential Public Health Services (EPHS).The 10 EPHS include:1. Assess and monitor population health status, factors that influence health, and community needs and assets.2. Investigate, diagnose, and address health problems and hazards affecting the population.3. Communicate effectively to inform and educate people about health, factors that influence it, and how to improve it.4. Strengthen, support, and mobilize communities and partnerships to improve health.5. Create, champion, and implement policies, plans, and laws that impact health.6. Use legal and regulatory actions designed to improve and protect the publics health.7. Contribute to an effective system that enables equitable access to the individual services and care needed to be healthy.8. Build and support a diverse and skilled public health workforce.9. Improve and innovate public health functions through ongoing evaluation, research, and continuous quality improvement.10. Build and maintain a strong organizational infrastructure for public health.

Health
Native American tribal organizations
NCI Outstanding Investigator Award (R35 Clinical Trial Optional)
$600,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 7, 2024

Date Added

Jul 26, 2022

This funding opportunity provides long-term financial support to experienced cancer researchers who are pursuing innovative and high-risk projects that could lead to significant advancements in cancer science.

Education
State governments
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 7, 2025

Date Added

Nov 3, 2021

This grant provides funding for researchers to explore how the human microbiome influences immune responses to prevent cancer, aiming to identify new strategies for cancer prevention.

Education
State governments
Fiscal Year (FY) 2026 AmeriCorps State and National Native Nations Grants
$25,000
AmeriCorps
Federal

Application Deadline

May 20, 2026

Date Added

Mar 23, 2026

This funding opportunity provides financial support to federally recognized Indian Tribes and tribal organizations to implement community service initiatives that address pressing challenges and promote civic engagement, education, and cultural preservation within Native communities.

Community Development
Native American tribal organizations
NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Mar 9, 2023

This grant provides funding for U.S. students pursuing combined clinical and research doctoral degrees, enabling them to conduct their Ph.D. dissertation research within the NIH's Intramural Research Program while receiving mentorship and professional development.

Health
Individuals
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional)
$600,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Aug 14, 2025

Date Added

Sep 29, 2023

This funding opportunity supports research into innovative non-invasive brain stimulation techniques to treat substance use disorders, targeting under-explored brain areas and measuring treatment success indicators.

Education
State governments
Alzheimer;apos;s Drug-Development Program (U01 Clinical Trial Optional)
$1,500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 3, 2024

Date Added

Jun 26, 2024

This funding opportunity supports research institutions and organizations in developing new drugs to prevent, slow, or treat Alzheimer's disease through early-stage and preclinical studies.

Health
State governments